| Ruxolitinib and Lenalidomide for Patients With Myelofibrosis (NCT01375140) | M.D. Anderson Cancer Center | 2011-09-22 |
| Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy (NCT01430351) | M.D. Anderson Cancer Center | 2011-09-14 |
| Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU) (NCT02166879) | M.D. Anderson Cancer Center | 2011-09-02 |
| Objective Assessment of Technical Skills in Cardiothoracic Surgery (NCT01433029) | M.D. Anderson Cancer Center | 2011-09-01 |
| Outcome of Colonoscopy Screening and Surveillance (NCT01827241) | M.D. Anderson Cancer Center | 2011-09-01 |
| Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia (NCT01371630) | M.D. Anderson Cancer Center | 2011-08-26 |
| Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction (NCT03326570) | M.D. Anderson Cancer Center | 2011-08-25 |
| Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer (NCT01432132) | M.D. Anderson Cancer Center | 2011-08-24 |
| Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas (NCT01329900) | M.D. Anderson Cancer Center | 2011-08-22 |
| Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) (NCT01253460) | M.D. Anderson Cancer Center | 2011-08-22 |
| TPI 287 in Breast Cancer Metastatic to the Brain (NCT01332630) | M.D. Anderson Cancer Center | 2011-08-16 |
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies (NCT01421173) | M.D. Anderson Cancer Center | 2011-08-01 |
| Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix (NCT01365156) | M.D. Anderson Cancer Center | 2011-08-01 |
| Phase II Evaluation of Exhaled Nitric Oxide (NO) (NCT01392144) | M.D. Anderson Cancer Center | 2011-08-01 |
| Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF (NCT01367275) | M.D. Anderson Cancer Center | 2011-08-01 |
| Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma (NCT01301807) | M.D. Anderson Cancer Center | 2011-07-28 |
| Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT01363128) | M.D. Anderson Cancer Center | 2011-07-12 |
| Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy (NCT01258933) | M.D. Anderson Cancer Center | 2011-07-06 |
| Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) (NCT01272245) | M.D. Anderson Cancer Center | 2011-07-01 |
| A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil (NCT01317550) | M.D. Anderson Cancer Center | 2011-07-01 |
| End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer (NCT01389830) | M.D. Anderson Cancer Center | 2011-06-30 |
| CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies (NCT00968760) | M.D. Anderson Cancer Center | 2011-06-20 |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer (NCT01377389) | M.D. Anderson Cancer Center | 2011-06-17 |
| Clearance Of Mucus In Stents (COMIS) (NCT01370278) | M.D. Anderson Cancer Center | 2011-06-16 |
| An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma (NCT03968315) | M.D. Anderson Cancer Center | 2011-06-08 |
| BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer (NCT01248247) | M.D. Anderson Cancer Center | 2011-06-02 |
| High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease (NCT01200329) | M.D. Anderson Cancer Center | 2011-06-01 |
| Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) (NCT01110876) | M.D. Anderson Cancer Center | 2011-06-01 |
| The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer (NCT01193530) | M.D. Anderson Cancer Center | 2011-06-01 |
| SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) (NCT01352520) | M.D. Anderson Cancer Center | 2011-06-01 |
| Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer (NCT01334021) | M.D. Anderson Cancer Center | 2011-05-31 |
| Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" (NCT01365169) | M.D. Anderson Cancer Center | 2011-05-25 |
| Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer (NCT01330446) | M.D. Anderson Cancer Center | 2011-05-19 |
| BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer (NCT01263782) | M.D. Anderson Cancer Center | 2011-05-17 |
| Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone (NCT05049785) | M.D. Anderson Cancer Center | 2011-05-12 |
| Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor (NCT01277744) | M.D. Anderson Cancer Center | 2011-05-09 |
| Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma (NCT01208103) | M.D. Anderson Cancer Center | 2011-05-06 |
| Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients (NCT01169753) | M.D. Anderson Cancer Center | 2011-05-01 |
| Stage I/II Nasal NK Cell Lymphoma (NCT01321008) | M.D. Anderson Cancer Center | 2011-05-01 |
| Tolvaptan in Hyponatremic Cancer Patients (NCT01199198) | M.D. Anderson Cancer Center | 2011-05-01 |
| Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer (NCT01266057) | M.D. Anderson Cancer Center | 2011-04-28 |
| Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies (NCT01339871) | M.D. Anderson Cancer Center | 2011-04-20 |
| Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy (NCT01180959) | M.D. Anderson Cancer Center | 2011-04-14 |
| Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 (NCT01200485) | M.D. Anderson Cancer Center | 2011-04-01 |
| Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia (NCT00962715) | M.D. Anderson Cancer Center | 2011-04-01 |
| TEST: Registry for Endoscopic Head and Neck Surgery (NCT01412749) | M.D. Anderson Cancer Center | 2011-04-01 |
| 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer (NCT01162785) | M.D. Anderson Cancer Center | 2011-04-01 |
| Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis (NCT01295645) | M.D. Anderson Cancer Center | 2011-03-17 |
| Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies (NCT01254864) | M.D. Anderson Cancer Center | 2011-03-16 |
| Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma (NCT01198028) | M.D. Anderson Cancer Center | 2011-03-10 |
| Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (NCT01243190) | M.D. Anderson Cancer Center | 2011-03-01 |
| Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors (NCT01311856) | M.D. Anderson Cancer Center | 2011-03-01 |
| Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients (NCT01321879) | M.D. Anderson Cancer Center | 2011-03-01 |
| PKC412 and 5-Azacytidine (NCT01202877) | M.D. Anderson Cancer Center | 2011-03-01 |
| Diabetic Treatment Adherence (NCT01318564) | M.D. Anderson Cancer Center | 2011-03-01 |
| Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma (NCT01092728) | M.D. Anderson Cancer Center | 2011-03-01 |
| High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI (NCT01266603) | M.D. Anderson Cancer Center | 2011-02-22 |
| Relaxation for Women With Breast Cancer Undergoing Radiotherapy (NCT01202851) | M.D. Anderson Cancer Center | 2011-02-10 |
| Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer (NCT01266642) | M.D. Anderson Cancer Center | 2011-02-08 |
| Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (NCT01289457) | M.D. Anderson Cancer Center | 2011-02-02 |
| Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain (NCT01278225) | M.D. Anderson Cancer Center | 2011-02-01 |
| Nuclear and Near-Infrared (NIR) Imaging in Melanoma (NCT01295931) | M.D. Anderson Cancer Center | 2011-02-01 |
| Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin (NCT01059305) | M.D. Anderson Cancer Center | 2011-02-01 |
| Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction (NCT01310075) | M.D. Anderson Cancer Center | 2011-02-01 |
| Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) (NCT01263769) | M.D. Anderson Cancer Center | 2011-02-01 |
| Virtual Reality Intervention in Cancer Genetics (NCT01310829) | M.D. Anderson Cancer Center | 2011-02-01 |
| Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma (NCT01169636) | M.D. Anderson Cancer Center | 2011-01-31 |
| Prevention of Treatment Induced Neuropathy in Multiple Myeloma (NCT01283997) | M.D. Anderson Cancer Center | 2011-01-25 |
| Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) (NCT01032278) | M.D. Anderson Cancer Center | 2011-01-25 |
| Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial (NCT01217931) | M.D. Anderson Cancer Center | 2011-01-19 |
| Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble (NCT01224288) | M.D. Anderson Cancer Center | 2011-01-05 |
| Obesity: Cancer Risk Among African Americans (NCT01294657) | M.D. Anderson Cancer Center | 2011-01-01 |
| Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome (NCT01254890) | M.D. Anderson Cancer Center | 2011-01-01 |
| Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas (NCT01276613) | M.D. Anderson Cancer Center | 2011-01-01 |
| The Role of the EKG in Anticancer Drug Development (NCT01462383) | M.D. Anderson Cancer Center | 2011-01-01 |
| Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer (NCT01259284) | M.D. Anderson Cancer Center | 2011-01-01 |
| Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST) (NCT01270893) | M.D. Anderson Cancer Center | 2011-01-01 |
| Reducing Tobacco Related Health Disparities (NCT00984724) | M.D. Anderson Cancer Center | 2011-01-01 |
| Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery (NCT01269190) | M.D. Anderson Cancer Center | 2010-12-30 |
| Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression (NCT01256554) | M.D. Anderson Cancer Center | 2010-12-03 |
| Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC) (NCT01254903) | M.D. Anderson Cancer Center | 2010-12-03 |
| Delayed-Delayed Breast Reconstruction (NCT01256528) | M.D. Anderson Cancer Center | 2010-12-01 |
| Phase l/II Study of Ruxolitinib for Acute Leukemia (NCT01251965) | M.D. Anderson Cancer Center | 2010-12-01 |
| Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma (NCT01200342) | M.D. Anderson Cancer Center | 2010-12-01 |
| Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer (NCT01245712) | M.D. Anderson Cancer Center | 2010-11-15 |
| High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma (NCT01237951) | M.D. Anderson Cancer Center | 2010-11-08 |
| Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery (NCT00985400) | M.D. Anderson Cancer Center | 2010-11-05 |
| Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) (NCT01168921) | M.D. Anderson Cancer Center | 2010-11-03 |
| CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater (NCT01202409) | M.D. Anderson Cancer Center | 2010-11-02 |
| Study of SB939 in Subjects With Myelofibrosis (NCT01200498) | M.D. Anderson Cancer Center | 2010-11-01 |
| Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer (NCT01036087) | M.D. Anderson Cancer Center | 2010-11-01 |
| Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations (NCT00943943) | M.D. Anderson Cancer Center | 2010-10-29 |
| Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (NCT01198067) | M.D. Anderson Cancer Center | 2010-10-06 |
| Trimodality Management of T1b Esophageal Cancers (NCT01217060) | M.D. Anderson Cancer Center | 2010-10-01 |
| Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab (NCT01213238) | M.D. Anderson Cancer Center | 2010-09-30 |
| Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients (NCT02160366) | M.D. Anderson Cancer Center | 2010-09-27 |
| Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer (NCT01205672) | M.D. Anderson Cancer Center | 2010-09-16 |
| Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance (NCT01197170) | M.D. Anderson Cancer Center | 2010-09-07 |
| Neoadjuvant Ipilimumab in Prostate Cancer (NCT01194271) | M.D. Anderson Cancer Center | 2010-09-01 |
| Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia (NCT01204788) | M.D. Anderson Cancer Center | 2010-09-01 |